We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Evidence of Mpox Virus Infection Among Persons Without Characteristic Lesions or Rash Presenting for First Dose of JYNNEOS Vaccine—District of Columbia, August 2022.
- Authors
Ogale, Yasmin P; Baird, Nicolle; Townsend, Michael B; Berry, Isha; Griffin, Isabel; Lee, Michelle; Ashley, Patrick; Rhodes, Trevor; Notigan, Tiffany; Wynn, Nhien; Kling, Chantal; Smith, Todd; Priyamvada, Lalita; Carson, William C; Navarra, Terese; Dawson, Patrick; Weidle, Paul J; Willut, Christina; Mangla, Anil T; Satheshkumar, Panayampalli S
- Abstract
We assessed mpox virus prevalence in blood, pharyngeal, and rectal specimens among persons without characteristic rash presenting for JYNNEOS vaccine. Our data indicate that the utility of risk-based screening for mpox in persons without skin lesions or rash via pharyngeal swabs, rectal swabs, and/or blood is likely limited.
- Subjects
WASHINGTON (D.C.); PREVENTION of infectious disease transmission; IMMUNIZATION; MONKEYPOX; EXANTHEMA; SMALLPOX vaccines; RISK assessment; DISEASE risk factors; INFECTIOUS disease transmission; SYMPTOMS
- Publication
Clinical Infectious Diseases, 2023, Vol 77, Issue 2, p298
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciad145